Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001515489 | SCV001723576 | benign | Inflammatory bowel disease | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004713173 | SCV005281805 | benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000018369 | SCV000038650 | risk factor | Susceptibility to HIV infection | 2003-12-04 | no assertion criteria provided | literature only | |
OMIM | RCV000022522 | SCV000043811 | protective | Graft-versus-host disease, resistance to | 2003-12-04 | no assertion criteria provided | literature only | |
Department of Surgery, |
RCV003311662 | SCV004011742 | other | Cholangiocarcinoma | 2022-12-10 | no assertion criteria provided | research | No association with disease-free or overall survival after resection of intrahepatic Cholangiocarcinoma |